Can We Miss Pigmented Lesions in Psoriasis Patients?
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01053819|
Recruitment Status : Completed
First Posted : January 21, 2010
Results First Posted : August 22, 2012
Last Update Posted : February 23, 2018
|Condition or disease||Intervention/treatment||Phase|
|Psoriasis Melanoma Non-melanoma Skin Cancer||Drug: etanercept||Phase 4|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||6 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||Can We Miss Pigmented Lesions in Psoriasis Patients?|
|Study Start Date :||September 2007|
|Actual Primary Completion Date :||April 2012|
|Actual Study Completion Date :||April 2012|
open label treatment(50 mg SQ)per Food and Drug Administration approval for 24 weeks
Patients will receive six months of treatment with Enbrel 50mg SQ given twice a week for the first three months and 50 mg once a week thereafter.
Other Name: Enbrel
- The Primary Endpoint for This Study Will be a Change From Baseline in the Number of Pigmented Lesions on Skin Previously Covered by Psoriatic Plaques. [ Time Frame: Patients will complete study within 6 months. ]
- A Secondary Objective Will be to Evaluate the Identified Pigmented Lesions for Suspicious Criteria [ Time Frame: Patients will complete the study within 6 months ]The data for this Outcome was not collected and due to the length of time, the records have been destroyed.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01053819
|United States, Alabama|
|Birmingham, Alabama, United States, 35233|
|Principal Investigator:||Boni E Elewski, MD||University of Alabama at Birmingham|